Summary
Global Markets Directs, Pompe Disease - Pipeline Review, H1 2012, provides an overview of the Pompe Disease therapeutic pipeline. This report provides information on the therapeutic development for Pompe Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pompe Disease. Pompe Disease - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Pompe Disease.
- A review of the Pompe Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Table of contents:
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Pompe Disease Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Pompe Disease 6
Pompe Disease Therapeutics under Development by Companies 8
Pompe Disease Therapeutics under Investigation by Universities/Institutes 9
Mid Clinical Stage Products 10
Comparative Analysis 10
Pre-Clinical Stage Products 11
Comparative Analysis 11
Pompe Disease Therapeutics Products under Development by Companies 12
Pompe Disease Therapeutics Products under Investigation by Universities/Institutes 13
Companies Involved in Pompe Disease Therapeutics Development 14
Genzyme Corporation 14
BioMarin Pharmaceutical Inc. 15
Pompe Disease Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Drug Profiles 21
BMN-701 - Drug Profile 21
Product Description 21
Mechanism of Action 21
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012PubId=pagenum=1
Tachycardia (Tachyarrhythmias) Pipeline Review, H1 2012
Genital Warts (Condylomata Acuminata) Pipeline Review, H1 2012
Gingivitis Pipeline Review, H1 2012
West Nile Virus Infections Pipeline Review, H1 2012
Pompe Disease Pipeline Review, H1 2012
Bronchiolitis Obliterans Pipeline Review, H1 2012
Cancer Cachexia Pipeline Review, H1 2012
Hyperuricemia Pipeline Review, H1 2012
Sarcoidosis Pipeline Review, H1 2012
Optic Nerve Injury Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and HealthcarePubId=pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com
